Qsymia vs Contrave: The Non-GLP-1 Weight Loss Pills Compared
Not everyone can take a GLP-1 - and not everyone wants to inject. Qsymia, Contrave, phentermine, and orlistat are the oral alternatives your doctor can still prescribe. Here is how they compare on effectiveness, side effects, and cost, plus an honest look at where they sit against the injectables.
Last updated: August 3, 2026
Quick Answer
Qsymia is generally the more effective of the two, and it is dramatically cheaper. Research comparing the two has found Qsymia usually outperforms Contrave on weight loss. On price the gap is stark: Qsymia is advertised at around $70 per month on 90-day prescriptions (with home delivery around $89), while Contrave runs $750-$790 per month without insurance - though discount cards can bring both down substantially.
Contrave also carries a notable tolerability problem: it has one of the highest discontinuation rates among oral weight loss agents - by some accounts higher even than GLP-1s - and almost always because of nausea.
The honest caveat: both produce far less weight loss than GLP-1 medications. These are the right tools when a GLP-1 is contraindicated, unaffordable, unavailable, or refused - not a first-line equivalent.
The Non-GLP-1 Landscape
GLP-1 medications dominate the conversation, but they are not the only FDA-approved prescription option for weight management. As of 2026, roughly a dozen medications carry weight loss approvals, and several of them are ordinary oral pills.
These drugs matter for a specific and often overlooked group of patients:
- People with a contraindication to GLP-1s - notably a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
- People who tried a GLP-1 and could not tolerate the gastrointestinal side effects
- People whose insurance excludes GLP-1s but covers older agents
- People who genuinely will not inject, and for whom the oral GLP-1 options are still out of reach
- People for whom $300-$450 monthly is simply not possible
For that group, "GLP-1 or nothing" is a false choice - and nothing is the worse option.
Qsymia: How It Works
Qsymia is a once-daily oral capsule combining phentermine and topiramate in extended-release form. The two components attack appetite from different directions:
- Phentermine is a sympathomimetic amine - a stimulant that suppresses appetite through effects on norepinephrine signaling. It has been used for weight loss since the 1950s.
- Topiramate is an anticonvulsant also used for migraine prevention. Weight loss was noticed as a side effect in epilepsy patients, and the mechanism is not fully understood, but it appears to reduce appetite and alter taste perception - particularly making carbonated drinks taste unpleasant.
The combination allows lower doses of each than would be needed alone, which improves the side effect profile relative to full-dose phentermine or topiramate monotherapy.
Qsymia Cost
Qsymia is advertised at around $70 per month on 90-day prescriptions, with home delivery pharmacy pricing around $89. Note that 90-day prescriptions are not available in all states. Discount card pricing can bring costs lower still. Combined with manufacturer savings programs, non-GLP-1 pills like Qsymia typically land around $100 per month or less - a fraction of GLP-1 pricing.
Key Considerations
- Stimulant effects. Insomnia, elevated heart rate, dry mouth, and anxiety are common. Not appropriate for everyone with cardiovascular disease or uncontrolled hypertension.
- Cognitive effects from topiramate. Word-finding difficulty and mental fogginess are well documented and are the most common reason patients stop.
- Tingling in hands and feet (paresthesia) is very common and usually harmless.
- Serious birth defect risk. Topiramate is associated with cleft lip and palate. Pregnancy prevention and testing requirements apply.
- Mood effects. Topiramate can affect mood in some patients - worth monitoring, particularly with a history of depression.
Contrave: How It Works
Contrave combines naltrexone and bupropion in an extended-release tablet, taken twice daily. It is the most mechanistically interesting of the oral options:
- Bupropion is an antidepressant (also marketed for smoking cessation) that affects dopamine and norepinephrine, stimulating neurons involved in appetite regulation.
- Naltrexone is an opioid antagonist used for alcohol and opioid dependence. It blocks a feedback loop that would otherwise blunt bupropion's appetite effect.
Because both components act on reward pathways rather than purely on hunger, Contrave is sometimes favored for patients whose eating is driven by craving and reward-seeking rather than physical hunger.
Contrave Cost
Without insurance, brand-name Contrave runs $750-$790 per month - genuinely expensive for a non-GLP-1 oral medication, and more than brand-name Zepbound costs through self-pay. Discount cards and manufacturer savings programs can reduce this substantially, and with a savings program it can land nearer $100 per month, but the list pricing is a real obstacle.
Key Considerations
Contrave has one of the highest discontinuation rates among oral weight loss agents - by some clinical accounts higher even than GLP-1s - and it is almost always due to nausea. That is worth knowing before you start, because it changes how you should approach titration: slow escalation is not optional.
- Nausea - the dominant side effect and main reason for stopping.
- Boxed warning for suicidal thoughts and behaviors. Bupropion carries this warning, particularly relevant in younger patients and those with psychiatric history.
- Seizure risk. Bupropion lowers the seizure threshold. Contraindicated in seizure disorders, bulimia or anorexia history, and abrupt alcohol or sedative withdrawal.
- Cannot be used with opioids. Naltrexone blocks opioid receptors - a serious issue for anyone requiring opioid pain management.
- Blood pressure and heart rate increases. Requires monitoring.
- Twice-daily dosing is more demanding than once-daily alternatives.
Head-to-Head Comparison
| Factor | Qsymia | Contrave |
|---|---|---|
| Components | Phentermine + topiramate | Naltrexone + bupropion |
| Dosing | Once daily | Twice daily |
| Relative effectiveness | Usually the more effective option | Generally less |
| Cost without insurance | ~$70-$89/month | $750-$790/month |
| Main side effect issue | Cognitive fog, tingling, insomnia | Nausea - high discontinuation |
| Boxed warning | No (but major pregnancy risk) | Yes - suicidal thoughts/behaviors |
| Best suited for | General appetite suppression | Craving and reward-driven eating |
| Avoid if | Pregnancy, glaucoma, uncontrolled hypertension, hyperthyroidism | Seizure disorder, eating disorder history, opioid use |
On the two factors most patients care about - effectiveness and cost - Qsymia wins both, and on cost it is not close. Contrave's case rests on mechanism: if your eating is driven by craving and reward rather than physical hunger, and particularly if you also have depression or are trying to quit smoking, the bupropion component may address more than one problem at once.
Phentermine and Orlistat
Two other non-GLP-1 options round out the category.
Phentermine (Adipex-P)
The single-agent stimulant appetite suppressant, and by far the cheapest prescription weight loss option - discount pricing can bring it into the low tens of dollars per month.
The catch: it is typically approved for short-term use - generally a few weeks - rather than the chronic management that obesity actually requires. It is a controlled substance with abuse potential, carries stimulant cardiovascular considerations, and tolerance to its appetite effect develops. It is often prescribed off-label for longer, but that is a decision to make explicitly with a doctor.
Orlistat (Xenical, Alli)
The mechanistic outlier - it does not affect appetite at all. Orlistat blocks lipase, the enzyme that digests dietary fat, so roughly a quarter of the fat you eat passes through undigested.
The catch: that undigested fat has to go somewhere, and the resulting gastrointestinal effects - oily stools, urgency, and flatulence with discharge - are the reason most people stop. It is available over the counter at lower strength as Alli. It also reduces absorption of fat-soluble vitamins, so supplementation is needed. Effectiveness is modest.
For a broader look at what does and does not work in this category, see our guide on whether weight loss pills work.
How They Compare to GLP-1s
This is the comparison that determines whether a non-GLP-1 pill is right for you, and it needs to be stated without softening.
| Medication | Form | Typical Weight Loss | Monthly Cost |
|---|---|---|---|
| Zepbound (tirzepatide) | Weekly injection | ~20-22% | $299-$449 |
| Wegovy (semaglutide) | Weekly injection | ~15% | $149-$399 |
| Foundayo (orforglipron) | Daily pill | ~11-12.4% | $149-$349 |
| Qsymia | Daily pill | Modest - well below GLP-1s | ~$70-$89 |
| Contrave | Twice-daily pill | Modest - below Qsymia | $750-$790 (much less with savings) |
| Phentermine alone | Daily pill | ~5%, short-term use | Very low |
The critical observation: Foundayo is a daily pill that delivers roughly 11-12% weight loss for $149-$349 per month. That did not exist a few years ago, and it substantially undercuts the traditional case for Qsymia and Contrave. If your objection to GLP-1s is needles rather than cost or contraindication, an oral GLP-1 is now the better answer. See our Foundayo review and Wegovy pill review.
Note also that Contrave's list price exceeds brand-name Zepbound's self-pay price while delivering substantially less weight loss. Anyone weighing Contrave purely on cost should check what a GLP-1 would actually cost them before assuming the pill is the budget option.
When a Non-GLP-1 Is the Right Choice
Consider Qsymia If You:
- Cannot take a GLP-1 due to contraindication or intolerance
- Need the lowest possible cost - $70-$89/month is genuinely accessible
- Have no cardiovascular contraindications to a stimulant
- Are not pregnant and can reliably prevent pregnancy - the topiramate birth defect risk is serious
- Want once-daily dosing rather than twice
Consider Contrave If You:
- Struggle with cravings and reward-driven eating rather than physical hunger
- Also have depression that the bupropion component may help address
- Are trying to quit smoking - bupropion is used for that indication too
- Cannot tolerate stimulants and so cannot use Qsymia
- Have coverage or savings program access that brings the price down
Look at GLP-1s Instead If You:
- Have significant weight to lose. The effectiveness gap is large and compounds at higher starting weights.
- Object to needles but not to cost. Oral GLP-1s now exist and outperform these pills.
- Have type 2 diabetes, sleep apnea, or cardiovascular disease. GLP-1s have specific evidence and, in Zepbound's case, a specific sleep apnea approval.
- Are eligible for the Medicare GLP-1 Bridge, where a $50 copay makes GLP-1s cheaper than Contrave.
Before You Settle for Less Effective
If cost is what pushed you toward an oral alternative, check the real numbers first. Physician-supervised compounded semaglutide from Coreage Rx starts at $249/month all-in - less than brand-name Contrave, with roughly triple the weight loss.
Frequently Asked Questions
Which is better, Qsymia or Contrave?
Qsymia for most people. Research comparing the two has found Qsymia is usually the more effective option, and the cost difference is dramatic - roughly $70-$89 per month versus $750-$790 without insurance. Contrave's case is mechanistic: it targets reward and craving pathways rather than pure appetite, which may suit patients whose eating is craving-driven, especially alongside depression or smoking cessation.
Is Qsymia a pill or an injection?
Qsymia is an oral capsule taken once daily. It combines phentermine and topiramate in extended-release form. That once-daily oral dosing is one of its practical advantages over Contrave, which requires twice-daily tablets.
How much does Contrave cost without insurance?
Roughly $750-$790 per month for the brand-name product - more than brand-name Zepbound costs through LillyDirect self-pay, while delivering substantially less weight loss. Manufacturer savings programs and discount cards can reduce this considerably, in some cases to around $100 per month. If you are considering Contrave on cost grounds, price a GLP-1 first before assuming the pill is cheaper.
Why do so many people stop taking Contrave?
Nausea. Contrave has one of the highest discontinuation rates among oral weight loss agents - by some clinical accounts higher even than GLP-1 medications - and it is almost always due to nausea. This makes slow, careful dose escalation essential rather than optional. If you start Contrave, discuss a conservative titration schedule with your prescriber up front.
How does Qsymia affect mood?
The topiramate component can affect mood in some patients, and cognitive effects such as word-finding difficulty and mental fogginess are well documented - these are among the most common reasons patients discontinue. The phentermine component is a stimulant and can contribute to anxiety and insomnia. If you have a history of depression or anxiety, raise it before starting so your prescriber can monitor appropriately.
Can you drive on Contrave?
Contrave can cause dizziness and drowsiness, particularly during dose escalation, so you should understand how it affects you before driving or operating machinery. This is standard advice for the medication rather than an absolute prohibition. If you experience persistent dizziness or sedation, tell your prescriber rather than simply pushing through it.
Are these pills as good as Ozempic or Wegovy?
No. GLP-1 medications produce substantially more weight loss - roughly 15% for semaglutide and 20-22% for tirzepatide, versus modest single-digit results typical of the older oral agents. Non-GLP-1 pills are the right choice when a GLP-1 is contraindicated, not tolerated, not covered, or genuinely unaffordable. They are not an equivalent alternative for someone who could take a GLP-1.
Is phentermine alone a cheaper option?
It is by far the cheapest prescription weight loss medication, but it comes with a significant limitation: it is typically approved for short-term use, generally a few weeks, rather than the chronic management obesity actually requires. It is a controlled substance with abuse potential, tolerance to its appetite effect develops, and it carries stimulant cardiovascular considerations. It is often prescribed off-label for longer periods, but that should be an explicit decision made with a doctor.
Who should not take Qsymia?
Qsymia should be avoided in pregnancy - the topiramate component is associated with cleft lip and palate, and pregnancy prevention and testing requirements apply. It is also generally avoided in glaucoma, hyperthyroidism, uncontrolled hypertension, and significant cardiovascular disease due to the stimulant component, and with MAO inhibitors. Discuss your full medical history and medication list with your prescriber before starting.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Qsymia, Contrave, phentermine, and orlistat are prescription medications that should only be used under the supervision of a qualified healthcare provider. Contrave carries a boxed warning for suicidal thoughts and behaviors and is contraindicated in seizure disorders and with opioid use. Qsymia carries serious pregnancy risks including birth defects, with pregnancy prevention and testing requirements. Phentermine is a controlled substance typically approved for short-term use. Weight loss figures represent typical outcomes and do not predict individual results. Pricing reflects publicly available information at the time of writing and changes frequently. Always review the full prescribing information and discuss your complete medical history and medication list with your doctor. HealthyPound may receive compensation from affiliate partners mentioned in this article. See our affiliate disclosure and full medical disclaimer for more information.